OCUL · NASDAQ

Ocular Therapeutix, Inc.

Q: How do I get OCUL news from the API?

Call GET /v1/news?tickers=OCUL. Add type=news, type=press_release, or type=legal to take one feed. Pro keys search the full archive in real time. Free keys are delayed 15 minutes and return the last year. Signed-out visitors and Free accounts see that same year on this page. Pro sees the full archive.

$6.50 +0.14 (+2.24%)

Company overview

Ocular Therapeutix, Inc., a biopharmaceutical company, focuses on the formulation, development, and commercialization of therapies for diseases and conditions of the eye using its bioresorbable hydrogel-based formulation technology. The company markets ReSure Sealant, an ophthalmic device to prevent wound leaks in corneal incisions following cataract surgery; and DEXTENZA, a dexamethasone ophthalmic insert to treat post-surgical ocular inflammation and pain following ophthalmic surgery, as well as allergic conjunctivitis.

Sector: Healthcare
Industry: Biotechnology
Exchange: NASDAQ
Market cap: $1.4B
Employees: 274
Headquarters: Bedford, MA
Website: ocutx.com
CEO: Pravin U. Dugel
Listed: July 25, 2014
P/E: -4.45
Dividend yield: 0.00%

Company financials

Revenue: $52M
Gross profit: $45.4M
Operating income: -$299M
EBITDA: -$282M
Net income: -$290M
EPS: -$1.46
Total assets: $733M
Total debt: $79.5M
Gross margin: 87.24%
Net margin: -558.24%
Earnings yield: -22.46%

Revenue segmentation

By product (FY 2025)

By region (FY 2025)

No geographic segmentation.

Showing FY 2025

Price chart

OCUL 1D NASDAQ O6.51H6.55L6.35C6.53-0.08 (-1.29%)Vol434.10K

News

Ticker	Type	Headline	Source	Published
Loading headlines…

FAQ

Questions about Ocular Therapeutix, Inc.

What does Ocular Therapeutix, Inc. do?

What is OCUL's market cap?

Ocular Therapeutix, Inc. (OCUL) is a listed stock with a live quote. The latest market cap on this page is $1.4B.

Where is Ocular Therapeutix, Inc. headquartered?

Ocular Therapeutix, Inc. is headquartered in Bedford, MA.

How do I get OCUL news from the API?

Call GET /v1/news?tickers=OCUL. Add type=news, type=press_release, or type=legal to take one feed. Pro keys search the full archive in real time. Free keys are delayed 15 minutes and return the last year. Signed-out visitors and Free accounts see that same year on this page. Pro sees the full archive.

How far back does OCUL news go?

Signed-out visitors and Free accounts see the last year of stock news, press releases, and legal notices for OCUL, 15 minutes behind, and each headline links to the publisher. Pro, including the 7-day trial, sees the full archive as headlines are ingested. A Free API key returns the last year. Pro keys search the full archive.

Is the OCUL price on this page from the API?

The price and daily change update during the US session for every visitor. That quote is context on this page. It is not part of the news API. The chart is one candle per session from the start of 2020. 1W, 1M, and 1Y group those sessions.

Real-time stock news for $15 a month.

Start a 7-day Pro trial. A card is required. REST, WebSocket, and MCP are included. If you don't subscribe, the account stays on Free.

Start 7-day free trial Read the docs